文献速递关节外科

机器人辅助与非机器人辅助骨水泥型全膝关节置换术早期翻修风险:美国关节置换登记分析

Robotic Assistance Is Not Associated With Decreased Early Revisions in Cementless TKA: An Analysis of the American Joint Replacement Registry.
PubMed 文献 · Clin Orthop Relat Res · 2024-11-21

基于美国关节置换登记(AJRR)的回顾性队列研究,纳入2017年1月至2020年3月≥65岁骨关节炎患者9220例,其中机器人辅助占45%(4130例)。控制混杂因素后,机器人辅助与非机器人辅助骨水泥型全膝关节置换术2年全因翻修OR为0.8(95%CI 0.5至1.3;p=0.41),无显著差异。

要点

  • 机器人辅助骨水泥型全膝关节置换术2年全因翻修OR 0.8(95%CI 0.5至1.3;p=0.41),无显著差异。
  • 机械松动翻修OR 3.2(95%CI 0.8至12;p=0.09),感染翻修OR 1.5(95%CI 0.8至2.6;p=0.19),均无显著差异。
  • 作者建议在缺乏患者可感知终点(疼痛、功能或生存率)证据前,不推荐广泛采用机器人辅助。

核心结论

  • 未发现机器人辅助改善骨水泥型全膝关节置换术2年无翻修假体生存率的证据。
  • 作者建议在精心设计的研究证明机器人辅助在患者可感知终点(如疼痛、功能或生存率)的价值之前,不推荐广泛采用。
  • 作者鼓励使用机器人辅助骨水泥型全膝关节置换术的外科医生和医疗机构研究其对患者结局的影响(如有)。

研究设计与样本

  • 回顾性队列研究,使用美国关节置换登记(AJRR)数据,纳入2017年1月至2020年3月≥65岁骨关节炎行初次全膝关节置换术且股骨和胫骨组件均为骨水泥型的患者。
  • 排除混合固定(仅胫骨或仅股骨使用骨水泥)手术。
  • 共纳入9220例患者,机器人辅助用于45%(4130例)手术。
  • 机器人辅助组女性比例略高(56%[2332/4130] vs 53%[2693/5090];p=0.002),Charlson合并症指数更高(2.9±0.9 vs 2.8±0.9;p=0.003),年龄无差异(72±5岁 vs 72±5岁;p=0.29)。
  • 采用混合效应模型分析全因翻修OR,调整年龄、性别、Charlson合并症指数、外科医生和机构。

主要发现

  • 控制混杂因素后,机器人辅助与非机器人辅助骨水泥型全膝关节置换术全因翻修OR为0.8(95%CI 0.5至1.3;p=0.41),无显著差异。
  • 机械松动翻修OR 3.2(95%CI 0.8至12;p=0.09),无显著差异。
  • 感染翻修OR 1.5(95%CI 0.8至2.6;p=0.19),无显著差异。
  • 功效分析显示能够检测两组翻修风险间小至0.5个标准差(基于Cohen d的中等效应量)的差异。

关键数值与推荐

  • 全因翻修OR 0.8(95%CI 0.5至1.3;p=0.41),机器人辅助 vs 非机器人辅助骨水泥型全膝关节置换术。
  • 机械松动翻修OR 3.2(95%CI 0.8至12;p=0.09),机器人辅助 vs 非机器人辅助骨水泥型全膝关节置换术。
  • 感染翻修OR 1.5(95%CI 0.8至2.6;p=0.19),机器人辅助 vs 非机器人辅助骨水泥型全膝关节置换术。

临床怎么用

  • 作者建议在精心设计的研究证明机器人辅助在患者可感知终点(如疼痛、功能或生存率)的价值之前,不推荐广泛采用机器人辅助骨水泥型全膝关节置换术。
  • 作者鼓励使用机器人辅助骨水泥型全膝关节置换术的外科医生和医疗机构研究其对患者结局的影响(如有)。

局限性

  • 机器人辅助骨水泥型全膝关节置换术超过2年的翻修几率差异仍未知,需要进一步的人群水平研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previously, we conducted a retrospective study of American Joint Replacement Registry (AJRR) data that examined the 2-year odds of revision between robotic-assisted and nonrobotic-assisted TKA, and we found no benefit to robotic assistance. However, proponents of robotic assistance have suggested that robot platforms confer more accurate bone cuts and precise implant sizing that might promote osteointegration of cementless implants by limiting micromotion at the bone-implant interface that could lead to aseptic loosening. Therefore, it seems important specifically to evaluate the odds of revision among patients with cementless implants only within our previous study population. QUESTIONS/PURPOSES: (1) After controlling for potentially confounding variables, such as surgeon, institution, and patient comorbidity profile, was robotic assistance associated with a decreased odds of 2-year revision of cementless TKA for any reason compared with cementless TKAs performed without robotic assistance? (2) After again controlling for potentially confounding variables, was robotic assistance associated with a decreased odds of 2-year revision of cementless TKA for particular revision indications (such as aseptic loosening, infection, instability, or pain) compared with the cementless TKAs performed without robotic assistance? METHODS: Using the AJRR, a retrospective cohort of patients ≥ 65 years of age with osteoarthritis who underwent primary TKA with cementless femur and tibial components from January 2017 through March 2020 was identified. Procedures performed with hybrid fixation (cement only on the tibia but not on the femur, or vice versa) were excluded. The AJRR was selected because it is the largest arthroplasty registry in the world by annual procedure volume, and it contains a data linkage with inpatient and outpatient Medicare claims data to ensure near-complete 2-year follow-up. A total of 9220 patients were identified, and robotic assistance was used in 45% (4130) of procedures. Patient age did not differ between groups (72 ± 5 years versus 72 ± 5 years; p = 0.29). However, the robotic-assisted cohort had a slightly higher proportion of female patients (56% [2332 of 4130] versus 53% [2693 of 5090]; p = 0.002) and higher Charlson comorbidity index (CCI) (2.9 ± 0.9 versus 2.8 ± 0.9; p = 0.003). Therefore, a mixed-effects model was used to analyze the ORs for all-cause linked revision with robotic assistance and was adjusted for age, gender, CCI, surgeon, and institution. Subanalyses were performed on indications for revision. A power analysis demonstrated the ability to measure a difference as small as one-half SD between risk of revision within each cohort (specifically, moderate effect sizes based on Cohen d). RESULTS: After controlling for potentially confounding variables, such as surgeon, location of surgery, and patient comorbidity profile, we found no difference regarding odds of all-cause revision between robotic-assisted and nonrobotic-assisted cementless TKA (OR of robotic-assisted versus nonrobotic-assisted cementless TKA 0.8 [95% CI 0.5 to 1.3]; p = 0.41). There were no differences in reasons for revision between robotic-assisted and nonrobotic-assisted cementless TKA, such as mechanical loosening (OR 3.2 [95% CI 0.8 to 12]; p = 0.09) and infection (OR 1.5 [95% CI 0.8 to 2.6]; p = 0.19). CONCLUSION: We found no evidence that robotic assistance improves the odds of cementless implant survival free from revision at 2 years. Importantly, the differences in odds of revision beyond 2 years as a function of robotic assistance in cementless TKA remains unknown and warrants further population-level investigation, but until or unless robotic assistance proves its value in well-designed studies in terms of endpoints that patients can perceive (such as pain, function, or survivorship), we recommend against widespread adoption until further evidence becomes available. Additionally, we encourage surgeons and healthcare facilities using robotic assistance in cementless TKAs to study its impact on patient outcomes, if any. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Kirchner GJ, Stambough JB, Jimenez E, et al. Robotic Assistance Is Not Associated With Decreased Early Revisions in Cementless TKA: An Analysis of the American Joint Replacement Registry. Clin Orthop Relat Res. 2024. PMID: 39569799. doi:10.1097/CORR.0000000000003330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。